Primary study · included by 1 review
Effect of hyaluronic acid on radiodermatitis in patients with breast cancer: a meta-analysis of randomized controlled trials.
Lee 2022 · Lee Chieh-Jui, Fang Hui-Fen, Wang Chin-Yun, et al. · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Radiodermatitis (RTOG/NCI) Topical hyaluronic acid with or without beta-glucan vs Grapevine extract, or shea butter plus grapevine extract plus glycyrrhetinic acid plus telmesteine | Dermatitis (RTOG/NCI) RR NS (3 RCTs, n = 120) | 3 studies · 120 participants | GRADE not reported |
Radiodermatitis (NCI) Topical hyaluronic acid vs Petrolatum-based substance or placebo cream | Dermatitis (NCI) RR NS (2 RCTs, n = 218) | 2 studies · 218 participants | GRADE not reported |
Radiodermatitis (RTOG/NCI) Topical hyaluronic acid with beta-glucan vs Phytosterols | RR 3.11 [1.82, 5.29] | 2 studies · 80 participants | GRADE not reported |
1 including review in total.